Skip to content

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Danaher logo
DanaherDHR
-0.8×
Azenta logo
AzentaAZTA
1.5×
LeMaitre Vascular logo
LeMaitre VascularLMAT
9.7×+1.3×
TEC
Bio-TechneTECH
6.8×-1.1×
CryoPort, Inc. logo
CryoPort, Inc.CYRX
0.0×

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on the most recent quarter.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's EV / sales?
BioLife Solutions (BLFS) reported EV / sales of 9.2× in Q1 2026.
How has BioLife Solutions's EV / sales changed year-over-year?
BioLife Solutions's EV / sales decreased by 30.3% year-over-year, from 13.2× to 9.2×.
What is the long-term trend for BioLife Solutions's EV / sales?
Over 3 years (2020 to 2025), BioLife Solutions's EV / sales has grown at a -28.2% compound annual growth rate (CAGR), from 32.9× to 12.2×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.